Podcasts about clinical neuroscience institute

Not another headache! But taking note of your symptoms and how often and how long headaches trouble you can provide vital information to relieve or even prevent them. In this Premier Health Now On-Air podcast, we talk about understanding and managing that pain in your head. You’ll learn what might trigger it, how your over-the-counter medication could make things worse, and an exciting new treatment to prevent migraines. Join headache specialist Dr. Richard Kim of the Clinical Neuroscience Institute for a healthy dose of pain relief.

Richard Kim, MD from the Clinical Neuroscience Institute reviews migraine treatments and devices.

Tracy Eicher, MD from the Clinical Neuroscience Institute discusses the shifts in philosophy of care for the multiple sclerosis patient.

Barbara Phillips, MD (general neurologist) from the Clinical Neuroscience Institute discusses medical uses for cannabis.

Christopher A. Scheiner, MD, Ph.D from The Clinical Neuroscience Institute discusses neuropathies that you can diagnose with the careful examination of the hand.

Fadi M. Tayim, Ph.D, from The Clinical Neuroscience Institute discusses the role of neurocognitive assessment in pre-surgical planning.

John B. Terry, MD from The Clinical Neuroscience Institute discusses management principles for spontaneous intracerebral hemorrhage.

There is nothing more important than good brain health and wellbeing throughout our lives. Yet while many people are concerned with their physical health and utilise wearable tech and mobile devises to monitor their exercise, steps, heart rate etc, we are not yet using technology to enhance our brain health and wellbeing. In this lecture, I will discuss how neuroscientists can work together with other experts in game development, IT and computing to develop enjoyable games for enhancing cognition, such as memory. In addition, I will discuss how we can use games to improve cognition, motivation and the ability to function in daily life for people with neuropsychiatric disorders, such as schizophrenia. Everyone likes to play games, so why not play one that is fun and good for your brain? Biography Barbara J Sahakian is Professor of Clinical Neuropsychology at the University of Cambridge Department of Psychiatry and MRC /Wellcome Trust Behavioural and Clinical Neuroscience Institute. She is also an Honorary Clinical Psychologist at Addenbrooke’s Hospital, Cambridge. She holds a PhD and a DSc from the University of Cambridge. She is President of the International Neuroethics Society, Past-President of the British Association for Psychopharmacology and a Fellow of the Academy of Medical Sciences. Sahakian is also a Member of the International Expert Jury for the 2017 Else Kröner-Fresenius-Stiftung Prize. She is a member of ACNP , CINP Council and ECNP Review Board and a member of the Human Brain Project. She is co-author of ‘Bad Moves: How decision making goes wrong and the ethics of smart drugs’ (Oxford University Press, 2013) and co-editor of The Oxford Handbook of Neuroethics (OUP, 2011). Sahakian has an international reputation in the fields of psychopharmacology, neuropsychology, neuropsychiatry, neuroimaging and neuroethics. She is perhaps best known for her work on ‘hot’ and ‘cold’ cognitive deficits in depression and early detection and early treatment with cholinesterase inhibitors in Alzheimer’s disease. She has over 390 publications in high impact scientific journals. The ISI Web of Science database credits her with a Hirsch (h) index of 102, with some publications having over 300 citations. Sahakian co-invented the neuropsychological CANTAB tests. She serves as a Senior Consultant to Cambridge Cognition, a University of Cambridge spin-out that provides CANTAB (www.cantab.com). She is also a Consultant for Peak (Brainbow) (https://itunes.apple.com/gb/app/peak-brain-training/id806223188?mt=8). Sahakian has contributed to Neuroscience and Mental Health Government Policy and has spoken on resilience, brain health, neuroscience and mental health at the World Economic Forum, Davos, 2014. She was also a finalist for a World Technology Award 2014 under the category of ‘Health and Medicine’. She is a member of the World Economic Forum Global Agenda Council on Brain Research.

John, an infantry officer for 19 years, was held up at gunpoint, bombed and saw friends and colleagues killed in action. He tells Claudia Hammond about the Post Traumatic Stress Disorder that he suffered when he left the armed forces. And in the first-ever UK study of military personnel in a theatre of war, in Iraq, to test mental health, the military is revealed to have experienced less psychological distress than police or fire officers. One of the study's co-authors, Professor Simon Wessely, Director of the King's Centre for Military Health Research, describes the mental health lessons that are being being learned from the front line. Antidepressants and Morality: Molly Crockett from the Behavioural and Clinical Neuroscience Institute at the University of Cambridge says how a particular group of anti depressants, SSRIs, Selective Serotonin Reuptake Inhibitors, have been found to increase morality by raising the levels of Serotonin in the brain. Community Treatment Orders: Introduced two years ago to enable people with mental illness to leave hospital and continue their treatment at home, new figures show ten times more CTOs have been issued than original Department of Health predictions. Reka, who has a diagnosis of bi-polar disorder, describes her experience of spending a year subject to a CTO, compelled to take injections of anti-psychotic medication which she says left her "like a zombie". Anthony Deary from the Care Quality Commission, Tony Maden, Professor of Forensic Psychiatry from Imperial College in London and Dr Tony Zigmond, mental health law lead for the Royal College of Psychiatrists discuss the reasons for the ballooning use of CTOs. Producer: Fiona Hill.